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Background: The vitamin D receptor (VDR) mediates the immunological function of vitamin D3, which activates
macrophages, and vitamin D deficiency has been linked to tuberculosis risk. Single nucleotide polymorphisms
(SNPs) in VDR may influence the function of vitamin D and susceptibility to tuberculosis.
Methods: This study included 217 patients with pulmonary tuberculosis (PTB) and 383 healthy subjects in a Tibetan
Chinese population living in and near Xi’an. Association analyses of SNPs in VDR were performed with the SPSS 17.0
statistical packages, SNP stats software, Haploview software package (version 4.2), and the SHEsis software platform.
Results: Our results revealed a correlation between three SNPs (rs11574143, odds ratio [OR]: 1.47, 95 % confidence
interval [CI]: 1.11 - 1.94, p = 0.006, p-adjust = 0.030; rs11574079, OR: 0.48, 95 % CI: 0.25 - 0.92, p = 0.023, p-adjust = 0.
115; rs11168287, OR: 2.55, 95 % CI: 2.00 - 3.25, p = 1.730E-14, p-adjust = 0.865E-13) and PTB based on Chi-square
tests. We observed the allele “A” of rs11574143 and rs11168287 increased the PTB risk and the allele “A” of
rs11574079 provided a protective effect against PTB.
Conclusions: The goal of this study was the identification of putative associations between five SNPs
(rs11574143, rs7975232, rs11574079, rs3819545 and rs11168287) in VDR and susceptibility to PTB.
Our findings demonstrated associations between VDR polymorphisms and PTB development.
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Pulmonary tuberculosis (PTB), which is, caused by the
human pathogen Mycobacterium tuberculosis, is a major
cause of morbidity and mortality in human populations
worldwide. Susceptibility to disease upon M. tuberculosis
infection is influenced by the agent, environmental and
host genetic factors [1]. Each year more than 9 million
people are infected by PTB and more than 1.7 million
succumb to PTB annually [2]. Cell-mediated immunity
is essential for the suppression of an M. tuberculosis
infection as it is an intracellular parasite [3]. The fact
that only 10 % of those infected with M. tuberculosis* Correspondence: klongli@163.com; jtianbo@126.com
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as well as environmental factors are involved in the
pathophysiology of PTB [4]. In addition, the host genetic
basis of PTB has been confirmed by twin studies that
indicated a two times higher risk of disease in identical
twins compared to non-identical twins [5]. There is a
much higher risk of severe disease and death in children
than in adults, therefore, the pediatric tuberculosis
remains a public health emergency [6]. Many studies
have shown that genetic factors play important roles in
PTB disease development, and vitamin D receptor (VDR)
gene has recently been found to be interesting candidate
genes.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Hu et al. BMC Infectious Diseases  (2016) 16:469 Page 2 of 7The active form of vitamin D, 1-25-dihydroxyvitamin D3,
is an important hormone that modulates the activity of
different defense and immune cells, including lymphocytes,
monocytes, macrophages and epithelial cells [7]. Vitamin D
restricts M. tuberculosis growth in macrophages through
the production of the anti-microbial peptide, cathelicidin
[8].Many studies showed an association between vitamin D
deficiency and certain diseases such as systemic lupus
erythematosus [9], diabetes mellitus [10], tuberculosis [11],
etc. During a tuberculosis infection, vitamin D binds to
VDR in macrophages, and this binging activates synthesis
of the antimicrobial peptide cathelicidin, which restricts M.
tuberculosis intracellular growth in macrophages [12], and
eliminates Mycobacterium tuberculosis in phagolysosomes
[13]. Thus, polymorphisms in VDR may contribute to PTB
susceptibility.
In this study, we evaluated the roles of VDR gene poly-
morphisms and haplotypes on PTB susceptibility by
conducting an extensive association analysis of a case–
control study in a Tibetan Chinese population. We found




From October 2012 to September 2013, we recruited 217
patients to participate in an ongoing molecular epidemio-
logical study at the Department of Respiratory Physicians
of the Tangdu Hospital affiliated with The Fourth Military
Medical University in Xi’an, China. The inclusion criteria
in the case group were newly diagnosed pulmonary tuber-
culosis patients, Tibetan ethnic, have symptoms of PTB,
positive sputum smear and chest radiography consistent
with active disease. The exclusion criteria in case group
were HIV positive, known to present diabetes mellitus and
other severe diseases, and consuming immunosuppressive
drugs.
From June 2012 to July 2013, we also recruited a ran-
dom sample of 383 unrelated healthy individuals at the
medical center of Tangdu Hospital to serve as controls.
All of the study participants were Tibetan Chinese living
in Xi’an and nearby. Controls subjects had no history PTB
and no evidence of prior PTB noted on chest radiography.
We enlisted them without regard to their age, gender, or
disease stage.
SNP selection and genotyping
We selected five single nucleotide polymorphisms (SNPs)
in VDR that had with minor allele frequencies (MAF) > 5 %
and were associated with PTB in the HapMap Asian popu-
lation. We extracted genomic DNA from peripheral blood
samples using the GoldMag-Mini Whole Blood Genomic
DNA Purification Kit (GoldMag Ltd. Xi'an, China) accord-
ing to the manufacturer's protocol. Sequenom MassARRAYAssay Design 3.0 Software was used to design primers for
amplification and extension reactions [14]. SNP genotyping
using the standard protocol recommended by the manufac-
turer was performed by Sequenom MassARRAY RS1000
[14]. Finally, Sequenom Typer 4.0 Software was used to
perform the data management and analysis [14, 15].Statistical analysis
We used Microsoft Excel and the SPSS 17.0 statistical
package (SPSS, Chicago, IL) to perform statistical analyses.
All of the p-values presented in this study are two-sided,
and p ≤ 0.05 was used as the threshold of statistical signi-
ficance. Departure from Hardy-Weinberg Equilibrium
(HWE) of each SNP frequency was assessed by an exact
test on the control subjects. We calculated the genotype
frequencies between the cases groups and control groups
by Chi-square test [16].
Odds ratios (OR) and 95 % confidence intervals (CI)
were calculated by unconditional logistic regression ana-
lyses [17]. We used the web-based software SNP stats to
test the associations between SNPs and the risk for PTB
in four genetic models (codominant, dominant, recessive,
and additive) [18].
The software platform (http://sampsize.sourceforge.net/
iface/s3.html) was used for evaluating the statistical power
of this case-control study. We used the Haploview soft-
ware package (version 4.2) and SHEsis software platform
(http://www.nhgg.org/analysis/) for analyses of linkage dis-
equilibrium, haplotype construction, and genetic associ-
ation at polymorphism loci [19, 20].Results
The PCR primers for the 5 selected SNPs, which were
designed using the Sequenom MassARRAY Assay Design
3.0 Software, were listed in Table 1.
Basic information of candidate SNPs in this study was
shown in Table 2. We also adjusted the p-value by Bon-
ferroni correction. It listed the minor allele frequency
(MAF) of cases and controls, we found there existed a
correlation between three loci (rs11574143, OR: 1.47, 95 %
CI: 1.11 - 1.94, p = 0.006, p-adjust = 0.030; rs11574079, OR:
0.48, 95 % CI: 0.25 - 0.92, p = 0.023, p-adjust = 0.115;
rs11168287, OR: 2.55, 95 % CI: 2.00 - 3.25; p = 1.730E-14,
p-adjust = 0.865 E-13) and PTB based on Chi-square tests.
Rs7975232 and rs3819545 had no connection with PTB
susceptibility. All of the tested SNPs conformed to HWE in
the control group of this study (p > 0.05). Post-hoc power
value we calculated of rs11574143, rs7975232, rs11574079,
rs3819545, rs11168287 were 77.59 %, 45.41 %, 62.96 %,
4.13 %, 100 %, respectively.
The relationships between rs11574143, rs11574079,
rs11168287 and PTB risk were listed in Table 3. We
observed the allele “A” of rs11574143 and rs11168287
Table 1 Primers used in this study
SNP ID 1st-PCR primer sequence 2nd-PCR primer sequence UEP sequence
rs11574143 ACGTTGGATGAACTGTGTCTGCCATTAGAG ACGTTGGATGTAGGAGTCCTGTTTCTGCAC cataCTCCAGGTCACTGGCA
rs7975232 ACGTTGGATGTGCCGTTGAGTGTCTGTGTG ACGTTGGATGTAGAGAAGAAGGCACAGGAG taagGGAGCTCTCAGCTGGGC
rs11574079 ACGTTGGATGTGAGGAAGAGCCTATGCTGG ACGTTGGATGGAGGGAAGCACCATCTCTTG cCCATCTCTTGCAGTAGC
rs3819545 ACGTTGGATGTTATCCTGTGGGTAGATCGG ACGTTGGATGTCATGGTCATTTAGGTTCGG AGGTTCGGTCTTTGGCT
rs11168287 ACGTTGGATGGGAGGAAAAGTCCAGATTTG ACGTTGGATGGGGTGAGGAGAAATGAGTTG gggaTTGTTCTAATCTCTCTCCTAACA
SNP single nucleotide polymorphism; PCR polymerase chain reaction; UEP unique base extension primer
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provided a protective effect against PTB.
For rs11574143, In the codominant model, the geno-
type “A/G” (OR =1.54; 95 % CI, 1.08 - 2.19; p = 0.024,
p-adjust = 0.12) increased PTB risk by 1.54-fold; In the
dominant model, the genotype “G/A” and “A/A” (OR =
1.59; 95 % CI, 1.13 - 2.23; p = 0.0077, p-adjust = 0.039)
increased PTB risk by 1.59-flod; In the additive model,
the allele “A” increased PTB risk by 1.48-fold (OR =
1.48; 95 % CI, 1.11 - 1.96; p = 0.0066, p-adjust = 0.033).
We also observed another susceptibility SNP, rs11168287,
p-value < 0.0001 (p-adjust < 0.0005) for all of the four
models in SNP analyses. In the codominant model, the
genotype “A/G” (OR = 2.38; 95 % CI, 1.57 - 3.60) and
“A/A” (OR = 6.07; 95 % CI, 3.69 - 9.97) increased PTB risk
by 2.38-fold and 6.07-fold respectively; In the dominant
model, the genotype “A/G” and “A/A” increased more
than 3-fold PTB risk (OR = 3.19; 95 % CI, 2.16 - 4.72); In
the recessive model, the genotype “A/A” increased PTB
risk by 3.60-fold (OR = 3.60; 95 % CI, 2.38 - 5.46). In the
additive model, the allele “A” increased PTB risk by
2.46-fold (OR = 2.46; 95 % CI, 1.92 - 3.15).
The SNP rs11574079 correlated with a protective
effect against PTB in the dominant model (OR: 0.48,
95 % CI: 0.24 - 0.92, p = 0.021, p-adjust =0.105) and in
the additive model (OR: 0.47, 95 % CI: 0.25 - 0.91, p =
0.018, p-adjust = 0.09).
A block (rs4947492 and rs12718945) was detected in
studied VDR SNPs by haplotype analyses (Fig. 1). The
results of the association between the VDR haplotype and
the risk of PTB were listed in Table 4. Altogether thereTable 2 Basic information of candidate SNPs in this study
SNP-ID Allele Gene Loc. MAF
Case Cont
rs11574143 A/G VDR 12q13.11 0.265 0.19
rs7975232 A/C VDR 12q13.11 0.327 0.27
rs11574079 A/G VDR 12q13.11 0.028 0.05
rs3819545 T/C VDR 12q13.11 0.274 0.27
rs11168287 A/G VDR 12q13.11 0.569 0.34
SNP single nucleotide polymorphism; MAF minor allele frequency; HWE Hardy-Wein
*p-value <0.05 indicates statistical significancewere three haplotypes and only the haplotype “A/A” was
found to increase risk of suffering from PTB by 1.45-fold
(OR = 1.45; 95 % CI, 1.09 - 1.94; p = 0.01). We adjusted
the p-value by Bonferroni correction, the haplotype “A/A”
still existed a statistically significant difference (p = 0.02).
Discussion
Our comprehensive analysis of SNPs in VDR suggests that
VDR genotypes and haplotypes associate with PTB risk.
We found two PTB risk associated SNPs, rs11574143 and
rs11168287, and one PTB protective SNP, rs11574079, in
VDR. The other two VDR SNPs, rs7975232 and rs3819545,
had did not associate with PTB susceptibility.
In previously published studies, there is no research
reported that the association between VDR gene and PTB
susceptibility. We for the first time studied the corre-
lations between three SNPs (rs11574143, rs11168287 and
rs11574079) in VDR gene and PTB susceptibility in a
Tibetan Chinese population, rs3819545 showed no corre-
lations with PTB susceptibility, and we got some valuable
results. Further studies should involve some others
regions and ethnic groups.
A few studies have analyzed the association between the
VDR ApaI (rs7975232) polymorphism and TB susceptibi-
lity. A study conducted by Selvaraj et.al. in the Indian
population shows that the ‘A/A’ genotype is associated
with resistance to pulmonary TB in males, but not in
females [21]. In a study carried out in pulmonary TB
patients of south India, the Bb genotype of VDR BsmI was
associated with susceptibility to TB, whereas A/A geno-
type of ApaI and B/B genotype of BsmI were associatedHWE-p OR (95 % CI) p-value p-adjusted
rol
7 1 1.47 (1.11-1.94) 0.006* 0.030*
7 0.799 1.27 (0.98-1.64) 0.066 0.330
6 1 0.48 (0.25-0.92) 0.023* 0.115
9 0.799 0.97 (0.75-1.27) 0.847 1
1 0.569 2.55 (2.00-3.25) 1.730E-14* 0.865E-13*
berg Equilibrium; OR odds ratio; CI confidence interval
Table 3 Associations between the SNP genotypes of VDR and the risk of PTB
SNP-ID Model Genotype Control (N,%) Case (N,%) OR (95 % CI) p-value p-adjusted
G/G 246 (64.6 %) 116 (53.5 %) 1
Codominant A/G 120 (31.5 %) 87 (40.1 %) 1.54 (1.08-2.19) 0.024* 0.12
A/A 15 (3.9 %) 14 (6.5 %) 1.98 (0.92-4.24)
rs11574143 Dominant G/G 246 (64.6 %) 116 (53.5 %) 1
G/A-A/A 135 (35.4 %) 101 (46.5 %) 1.59 (1.13-2.23) 0.0077* 0.039*
Recessive G/G-G/A 366 (96.1 %) 203 (93.5 %) 1
A/A 15 (3.9 %) 14 (6.5 %) 1.68 (0.80-3.56) 0.18 0.90
Log-additive — — — 1.48 (1.11-1.96) 0.0066* 0.033*
G/G 341 (89 %) 205 (94.5 %) 1
Codominant A/G 41 (10.7 %) 12 (5.5 %) 0.49 (0.25-0.95) 0.053 0.265
A/A 1 (0.3 %) 0 (0 %) 0.00 (0.00-NA)
rs11574079 Dominant G/G 341 (89 %) 205 (94.5 %) 1
A/G-A/A 42 (11 %) 12 (5.5 %) 0.48 (0.24-0.92) 0.021* 0.105
Recessive G/G-A/G 382 (99.7 %) 217 (100 %) 1
A/A 1 (0.3 %) 0 (0 %) 0.00 (0.00-NA) 0.34 1
Log-additive — — — 0.47 (0.25-0.91) 0.018* 0.09
G/G 168 (44.1 %) 43 (19.8 %) 1
Codominant A/G 166 (43.6 %) 101 (46.5 %) 2.38 (1.57-3.60) <0.0001* <0.0005*
A/A 47 (12.3 %) 73 (33.6 %) 6.07 (3.69-9.97)
rs11168287 Dominant G/G 168 (44.1 %) 43 (19.8 %) 1
A/G-A/A 213 (55.9 %) 174 (80.2 %) 3.19 (2.16-4.72) <0.0001* <0.0005*
Recessive G/G-A/G 334 (87.7 %) 144 (66.4 %) 1
A/A 47 (12.3 %) 73 (33.6 %) 3.60 (2.38-5.46) <0.0001* <0.0005*
Log-additive — — — 2.46 (1.92-3.15) <0.0001* <0.0005*
OR odds ratio; CI confidence interval; *: p-value <0.05 indicates statistical significance. SNP single nucleotide polymorphism; VDR vitamin D receptor;
PTB pulmonary tuberculosis
Fig. 1 Linkage disequilibrium patterns of five SNPs in VDR
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are inconsistent with the results of some previously pub-
lished studies, a possible explanation could be their ethnic
differences.
Comparisons with other researches showed that popula-
tion or various ethnicities give different results. Many
studies have suggested associations between VDR SNPs
and PTB in variety populations [22, 24, 25]. The different
results shown by Central Indian and South Indian popu-
lations may be due to the diversity of these two Indian
populations and their difference in origins [26]. A latest
study was in accordance with those obtained by other
authors for West African populations, but in total discre-
pancy with the results for Indian, Iranian and Chinese
populations [27]. Several case-control studies, performed
in populations with high TB incidence, had studied the
correlation between the VDR gene polymorphisms and
genetic susceptibility to PTB, but the results were incon-
clusive, presumably because the populations were ethni-
cally and geographically different and genetically diverse
[25, 28, 29]. Wei et al. reported no association was found
Table 4 Haplotype analysis results of rs11574143 and rs7975232 in VDR
SNP ID rs11574143 rs7975232 Freq OR (95 % CI) p-value p-adjusted
Haplotype G C 0.704 1 —
A A 0.221 1.45 (1.09-1.94) 0.01* 0.02*
G A 0.074 0.84 (0.52-1.36) 0.49 0.98
VDR: vitamin D receptor; SNP: single nucleotide polymorphism; OR: odds ratio; CI: confidence interval
*p-value <0.05 indicates statistical significance
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and susceptibility to pediatric PTB in the Chinese Han popu-
lation [30]. Also, a study in Cambodia [31] and Tanzania [32]
found no associations between VDR gene and PTB. These
differing results could be caused by gene-environment inter-
action, gene-gene interaction, and gene-agent interactions.
These reports suggest that the differing association results
between VDR genotypes in different ethnic populations may
result from gene-environment [33] and gene-gene inter-
actions [34, 35].
There are other factors that may influence the results. It
is known that before vitamin D enters the macrophage,
inactive vitamin D in serum could be bound to vitamin D
binding protein or in a free state. A recent study showed
that VDR variant (rs7968585) can predict risk for hip frac-
ture, cancer, myocardial infarction, and mortality among
older Caucasian individuals with a low vitamin D status
[36]. This association was only apparent in individuals
with a low vitamin D status, highlighting the importance
of taking into account gene-environment interactions.
Vitamin D status appears to be involved in the activation
of macrophages and restricts the intracellular develop-
ment of mycobacteria [37]. This effect of vitamin D may
be influenced by polymorphisms in the VDR gene. How-
ever, although the relationship between the internal envi-
ronment and the host gene is unknown, it may explain
the heterogeneity observed in the association studies and
it should be addressed as an influencing factor. The poly-
morphic variants of VDR gene along with other gene and
environmental factors may be responsible for an altered
cell-mediated immunity against M. tuberculosis in a sus-
ceptible or resistant host. Although several investigators
reported and suggested that the VDR polymorphism may
be of immune-regulatory significance for PTB but it is not
clear that the polymorphisms determine susceptibility to
the development of clinical disease or susceptibility to
infection. Further studies are required to determine how
VDR polymorphisms influence susceptibility to infection
or to clinical disease development. In order to understand
the pathogenesis of pulmonary TB that is useful for
prophylaxis and therapy. Ethnic-specific genetic asso-
ciation with TB susceptibility may guide TB therapy and
prophylaxis in an ethnic-specific manner. A post hoc power
analysis was conducted and the power analysis showed that
except rs11168287, other SNPs failed to reach minimum
level (80 %) for this case-control study. In this case, wecould not conclude that the difference was not statistically
significant, but need to increase sample size to verify.
Future research should pay attention to this point.
Because we limited ethnicity of our subjects to Tibetan
Chinese, and limited the locations of our subjects to Xi’an
City and its surrounding area, there were no substantial
population admixtures in our study populations. However,
some limitations should be considered when interpreting
our results. Our sample size was small and only included
217 PTB cases. Also, gene-environment and gene-gene
interactions may effect VDR expression and activity. And
the assessment of the environmental factors such as
tobacco, diet and alcohol consumption and the possibility
of inaccurate exposure should be considered. The suscep-
tibility and resistance to PTB are the result of the inter-
actions between environment, socioeconomic status and
host genes, therefore, further studies are required to eluci-
date the complex associations between the VDR gene
variants and the immune response against PTB. These
data will lead to a better understanding of the immuno-
logical and genetic pathways in tuberculosis, and will pro-
vide new ideas for potential treatments and prophylaxes
to reduce the prevalence and incidence of PTB caused by
M. tuberculosis infections.
Conclusions
Our findings demonstrated that genetic variants of VDR
play complex roles in the development of PTB and
provided new evidence for associations between SNPs
and haplotypes of VDR and the risk of PTB. This study
offers new information on the relationship between VDR
polymorphisms and PTB .Moreover, this study reveals the
molecular markers associated with of PTB susceptibility
and could therefore be used as diagnostic and prognostic
markers for PTB patients in clinical study.
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